Pulmonx Corp — Director's Dealing 2023

Mar 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-03-01

Reporting Person: Lehman David Aaron (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-01	Common Stock	S	458	$11.03	Disposed	43702	Direct
2023-03-01	Common Stock	S	806	$11.03	Disposed	42896	Direct
2023-03-01	Common Stock	A	118300	$0.00	Acquired	161196	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Employee Stock Option (right to buy)	$11.48	A	81000	Acquired	2033-02-28	Common Stock (81000)	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021.

F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022.

F3: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023.

F4: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023.